202 related articles for article (PubMed ID: 26231860)
1. Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study.
Kwon YS; Ha YS; Modi PK; Salmasi A; Parihar JS; Patel N; Faiena I; May M; Lee DI; Llukani E; Patrick T; Rha KH; Ahlering T; Skarecky D; Ahn H; Choi SK; Park S; Jeon SS; Ou YC; Eun D; Manucha V; Albala D; Badani K; Yuh B; Ruel N; Kim TH; Kwon TG; Marchalik D; Hwang J; Kim WJ; Kim IY
BMC Urol; 2015 Aug; 15():79. PubMed ID: 26231860
[TBL] [Abstract][Full Text] [Related]
2. Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series.
Ball MW; Harris KT; Schwen ZR; Mullins JK; Han M; Walsh PC; Partin AW; Epstein JI
BJU Int; 2017 Mar; 119(3):444-448. PubMed ID: 27611825
[TBL] [Abstract][Full Text] [Related]
3. Pathologic implications of prostatic anterior fat pad.
Jeong J; Choi EY; Kang DI; Ercolani M; Lee DH; Kim WJ; Kim IY
Urol Oncol; 2013 Jan; 31(1):63-7. PubMed ID: 21396837
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study.
Kim IY; Modi PK; Sadimin E; Ha YS; Kim JH; Skarecky D; Cha DY; Wambi CO; Ou YC; Yuh B; Park S; Llukani E; Albala DM; Wilson T; Ahlering T; Badani K; Ahn H; Lee DI; May M; Kim WJ; Lee DH
J Urol; 2013 Aug; 190(2):527-34. PubMed ID: 23485503
[TBL] [Abstract][Full Text] [Related]
5. [Lymph Node Metastasis to the Prostatic Anterior Fat Pad in the Patients Treated with Prostatectomy].
Shimizu Y; Ogawa K; Kida K; Tsuchihashi K; Kanamaru S; Ishihara M; Hashimoto K; Ito N
Hinyokika Kiyo; 2018 Sep; 64(9):359-363. PubMed ID: 30369226
[TBL] [Abstract][Full Text] [Related]
6. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
[TBL] [Abstract][Full Text] [Related]
7. Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?
Kluth LA; Xylinas E; Rieken M; Chun FK; Fajkovic H; Becker A; Karakiewicz PI; Passoni N; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Guillonneau B; Rouprêt M; Briganti A; Scherr DS; Graefen M; Tewari AK; Shariat SF
Urol Oncol; 2014 Jan; 32(1):47.e1-8. PubMed ID: 24055425
[TBL] [Abstract][Full Text] [Related]
8. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis.
Passoni NM; Fajkovic H; Xylinas E; Kluth L; Seitz C; Robinson BD; Rouprêt M; Chun FK; Lotan Y; Roehrborn CG; Crivelli JJ; Karakiewicz PI; Scherr DS; Rink M; Graefen M; Schramek P; Briganti A; Montorsi F; Tewari A; Shariat SF
BJU Int; 2014 Oct; 114(4):503-10. PubMed ID: 24053552
[TBL] [Abstract][Full Text] [Related]
10. Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience.
Pierorazio PM; Gorin MA; Ross AE; Feng Z; Trock BJ; Schaeffer EM; Han M; Epstein JI; Partin AW; Walsh PC; Bivalacqua TJ
Prostate; 2013 Nov; 73(15):1673-80. PubMed ID: 24019101
[TBL] [Abstract][Full Text] [Related]
11. [Landscape and metastases of the lymph nodes in prostatic anterior fat pad at radical prostatectomy].
Zhao DW; Zhou ZH; Zhao JL; Chen D; Yang ZY; Wang J; Long XB; Zhang YJ; Yang P; Cao Y; Li JB; Zhou FJ; Li YH
Zhonghua Wai Ke Za Zhi; 2022 Nov; 60(11):999-1003. PubMed ID: 36323582
[No Abstract] [Full Text] [Related]
12. Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes.
Ledezma RA; Negron E; Razmaria AA; Dangle P; Eggener SE; Shalhav AL; Zagaja GP
World J Urol; 2015 Nov; 33(11):1689-94. PubMed ID: 25701128
[TBL] [Abstract][Full Text] [Related]
13. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
14. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
15. Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer.
Mandel P; Kriegmair MC; Bogdan K; Boehm K; Budäus L; Graefen M; Huland H; Tilki D
Eur Urol Focus; 2017 Apr; 3(2-3):248-255. PubMed ID: 28753755
[TBL] [Abstract][Full Text] [Related]
16. Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancer.
González-Roibón N; Han JS; Lee S; Feng Z; Arslankoz S; Smith N; Pierorazio PM; Humphreys E; Deweese TL; Partin AW; Bivalacqua TJ; Han M; Trock B; Netto GJ
Int J Surg Pathol; 2013 Aug; 21(4):352-7. PubMed ID: 23564700
[TBL] [Abstract][Full Text] [Related]
17. Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment.
Mandel P; Rosenbaum C; Pompe RS; Steuber T; Salomon G; Chun FK; Graefen M; Huland H; Tilki D
World J Urol; 2017 Dec; 35(12):1833-1839. PubMed ID: 28828530
[TBL] [Abstract][Full Text] [Related]
18. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
19. Presence of lymph nodes and metastasis within prostatic anterior fat pad in radical prostatectomy patients: A single Chinese institution experience and literature review.
Hu M; Liao J; Cai W; Ling H; Wu D; Xu X; Zhu Q; Ye L
Eur J Surg Oncol; 2023 Dec; 49(12):107112. PubMed ID: 37832178
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
